ÂÜÀòÂÒÂ×

Jim Hill is a highly experienced professional in the pharmaceutical and healthcare industries, currently serving as a Board Member at AscellaHealth and Defender Pharmaceuticals, and as Chief Executive Officer of Pharma Strategy Group since 2008. Hill's career includes significant leadership roles, such as Chief Executive Officer of AcquireRx until its acquisition in April 2023, and Co-Founding Partner at Optime Care until its acquisition by AscellaHealth in December 2021. Hill has also held positions including Chairman of the Board at Providence Biotechnology Solutions and Vice President of Pharmaceutical Trade Relations at Express Scripts. Academic qualifications include an MBA in Finance from the Richard A. Chaifetz School of Business at Saint Louis University and a BS in Pharmacy from the University of Health Sciences and Pharmacy in St. Louis.